Establish Diagnostic and Prognostic Models for Preclinical AD Patients Based on Multimodal MRI, Behavioral, Genetic, and Plasma Biomarkers

Conditions

• Alzheimer Disease, Late Onset
• Mild Cognitive Impairment
• Subjective Cognitive Decline

Interventions

• OTHER: Multimodal magnetic resonance imaging scanning, behavioral, genetic and plasma biomarker testing

Sponsor

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School